Navigation Links
Synteract Unveils New Branding at DIA 2012 to Support Enhanced Commercial Strategy
Date:6/12/2012

SAN DIEGO and RALEIGH-DURHAM, N.C., June 12, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), will unveil its new branding at this year's Drug Information Association (DIA) annual meeting to be held from June 24-28 in Philadelphia at the Pennsylvania Convention Center. Synteract will exhibit in booth #1925. The company has revamped its brand to better showcase the full range of Phase I-IV services and expertise it offers biotechnology, medical device, and pharmaceutical companies.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

While the company's tagline – Shared Work-Shared Vision™ – has not changed, it has been enhanced by additional messaging that helps to define Synteract's updated commercial strategy and strong partnership approach. The company has evolved and expanded its service offering, scale and reach in response to client demand. The new brand platform serves to reinforce that updated perspective on Synteract to the industry. The company used images of its own people in its marketing because they are the cornerstone of the global clinical development and industry expertise supporting clients every day. 

The company's continued growth on the East Coast in Research Triangle Park and in Europe has been a driver for the revamped brand identity, according to Synteract CEO Wendel Barr. "Our updated brand position reflects the evolution and growth Synteract has achieved through our commitment to serving the unique needs of emerging to midsize biotech and pharma. Our high rate of repeat business is a testament to our success, as is our support of 22 product approvals. It's the commitment of our employees that has sustained our growth as well as that of our clients. Our continued dedication to great partnerships will be more clearly communicated through this revised messaging and strong visual identity that focuses on our people – they are Synteract."

As part of its strategy, the company is hiring to augment its medical, clinical, biostatistics and regulatory expertise and has increased its sales and marketing investment as well. The refocused brand identity includes a fully revamped website and tradeshow booths, increased advertising, public relations and social media efforts. Synteract's leaders are actively engaged in front of the medical, scientific and business communities through speaking engagements, contributed articles and interaction with industry associations and standards bodies such as CDISC, SCDM, DIA and others.

Barr added, "The new brand platform allows Synteract to more clearly address our differentiators within this competitive industry, giving current and prospective clients an overview of our customized approach and longstanding clinical development experience to facilitate their search for an outsourcing partner to match their specific needs. And as we move forward with European acquisition plans later this year, we want our culture to be clear."

At DIA, Synteract's growing team of drug development experts will be available to discuss the company's clinical development expertise. To set up an appointment in advance, contact Matt Smith, SVP Sales and Marketing at 760-795-2149 or msmith@synteract.com. The company will also host a reception at its booth on Monday, June 25th, 4:00 p.m.

About Synteract (www.synteract.com)
Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:

Rachel Hutman
Clearpoint Agency, for Synteract
rachel@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Synteract, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Synteract Director of IT Services Toby Odenheim Speaking at March 2012 Outsourcing in Clinical Trials East Coast Conference
2. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
3. SPYru™ unveils "The Uberwater"
4. Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salems Growing Piedmont Triad Research Park
5. MedTRACK Unveils Partnering Tool for J.P. Morgan Healthcare Conference
6. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
7. Fluke Biomedical training center goes global: adds multi-language support
8. MDA Supports Development of Dissociative Glucocorticoid for DMD
9. New Study: Health Professionals Support Biotechnologys Use In Food Products And Sustainable Farming
10. Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology
11. Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... (PRWEB) , ... February 10, ... ... REGN) today announced that it has joined the Human Vaccines Project, a ... infectious diseases and cancer. , The Human Vaccines Project brings together ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... three states, announced today the promotion of two long-standing principal investigators (PI) to ... Family Medicine, Clinical Research and Development. , Dr. Laurence Chu, a Benchmark Research ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads ... on the secure online PatientCrossroads platform, has exceeded both its one-year and overall ... the PROMPT study, which seeks to advance understanding of the hereditary risks for ...
(Date:2/10/2016)... ... February 09, 2016 , ... Creation Technologies, leading ... the Highest Overall Customer Rating Award from Circuits Assembly , today announced its ... the USA, Canada, Mexico and China. , The EMS provider, known in the ...
Breaking Biology Technology:
(Date:2/4/2016)... , Feb. 4, 2016 The ... apparently one of the most popular hubs of ... MetaHIT and other huge studies of human microbiota, ... past few years, the microbiome space has literally ... biomedical research. This report focuses on biomedical ...
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS ... are primarily focused on medical screening and ... point-of-care parameters. Wearable devices that facilitate and ... freedom of movement are being bolstered through ... human biomedical signal acquisition coupled with wireless ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
Breaking Biology News(10 mins):